High-dose cyclophosphamide for severe systemic lupus erythematosus.

Gladstone, D E; Prestrud, A A; Pradhan, A; Styler, M J; Topolsky, D L; Crilley, P A; Hoch, S; Huppert, A; Brodsky, I

Gladstone, D E; Prestrud, A A; Pradhan, A; Styler, M J; Topolsky, D L; Crilley, P A; Hoch, S; Huppert, A; Brodsky, I.

Affiliation

Gladstone DE; Drexel University, College of Medicine, Department of Medicine, Philadelphia, PA, USA. deg25@drexel.edu

Lupus ; 11(7): 405-10, 2002.

Article in En | MEDLINE | ID: mdl-12195780

Subject(s)

Cyclophosphamide/administration & dosage; Immunosuppressive Agents/administration & dosage; Lupus Erythematosus, Systemic/drug therapy; Adult; Female; Humans; Lupus Erythematosus, Systemic/diagnosis; Male; Middle Aged; Severity of Illness Index; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cyclophosphamide / Immunosuppressive Agents / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lupus Year: 2002 Document type: Article

Search on Google

XML

PubMed Links